Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ruxolitinib in Operable Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE1
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
- Status
- TERMINATED
- Phase
- PHASE2
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- Status
- RECRUITING
- Phase
- PHASE1
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2